-
Product Insights
NewApolipoprotein C – Drugs In Development, 2024
The Apolipoprotein C pipeline drugs market research report outlays comprehensive information on the Apolipoprotein C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Gastrointestinal, and Genetic Disorders which include indications of Hypertriglyceridemia, Familial Chylomicronemia (Type I Hyperlipoproteinemia), Hypertension, Unspecified Cardiovascular Disorders, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Hemochromatosis. It also reviews key players involved in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hepatitis C Vaccine in Hepatitis C
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hepatitis C Vaccine in Hepatitis C report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis C Vaccine in Hepatitis C Drug Details: Vaccine...
-
Product Insights
NewApolipoprotein C III – Drugs In Development, 2024
The Apolipoprotein C III pipeline drugs market research report outlays comprehensive information on the Apolipoprotein C III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Gastrointestinal, and Genetic Disorders which include indications of Hypertriglyceridemia, Familial Chylomicronemia (Type I Hyperlipoproteinemia), Hypertension, Unspecified Cardiovascular Disorders, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Hemochromatosis. It also reviews key players...
-
Product Insights
NewProtein Kinase C Theta Type – Drugs In Development, 2024
The Protein Kinase C Theta Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Theta Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Unspecified Cancer, Breast Cancer, Rheumatoid Arthritis, Inflammation, Obesity, Type 2 Diabetes, and Atopic Dermatitis (Atopic Eczema). It also...
-
Product Insights
NewVascular Endothelial Growth Factor C – Drugs In Development, 2024
The Vascular Endothelial Growth Factor C pipeline drugs market research report outlays comprehensive information on the Vascular Endothelial Growth Factor C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, Hematological Disorders, and Undisclosed which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Solid Tumor, Triple-Negative Breast Cancer (TNBC), Lymphedema, and Unspecified....
-
Product Insights
NewProtein Kinase C Epsilon Type – Drugs In Development, 2024
The Protein Kinase C Epsilon Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Epsilon Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Infectious Disease, and Oncology which include indications of Traumatic Brain Injury, Amyotrophic Lateral Sclerosis, Ischemia Reperfusion Injury, Ischemic Stroke, Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewProtein Kinase C Beta Type – Drugs In Development, 2024
The Protein Kinase C Beta Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Beta Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Ophthalmology, and Dermatology which include indications of Breast Cancer, Ovarian Cancer, Congestive Heart Failure (Heart Failure), Ischemia Reperfusion Injury, Diabetic Retinopathy, Hyperpigmentation, and Melasma (Chlosma). It...
-
Product Insights
NewDnaJ Homolog Subfamily C Member 15 – Drugs In Development, 2024
The DnaJ Homolog Subfamily C Member 15 pipeline drugs market research report outlays comprehensive information on the DnaJ Homolog Subfamily C Member 15 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Oncology, Genito Urinary System, and Genetic Disorders which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Hepatic Injury, Breast Cancer, Acute Renal Failure (ARF) (Acute Kidney...
-
Product Insights
NewMyristoylated Alanine Rich C Kinase Substrate – Drugs In Development, 2024
The Myristoylated Alanine Rich C Kinase Substrate pipeline drugs market research report outlays comprehensive information on the Myristoylated Alanine Rich C Kinase Substrate targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, Respiratory, and Immunology which include indications of Uveitis, Lung Cancer, Pediatric Cancer, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease (COPD), and Psoriasis. It...
-
Product Insights
NewTransient Receptor Potential Cation Channel Subfamily C – Drugs In Development, 2024
The Transient Receptor Potential Cation Channel Subfamily C pipeline drugs market research report outlays comprehensive information on the Transient Receptor Potential Cation Channel Subfamily C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Genito Urinary System, and Undisclosed which include indications of Traumatic Brain Injury, Major Depressive Disorder, Cardiovascular, Unspecified Cardiovascular Disorders, Focal...